Medifast Inc at ICR Conference Transcript

Jan 11, 2022 / 07:30PM GMT
Steph Wissink - Jefferies - Analyst

Good day, everyone. I am Steph Wissink, Senior Research Analyst from Jefferies. It's my pleasure today to be hosting the team from Medifast. On your screen next to me, you should see Dan Chard, the Company's CEO; and Jim Maloney, the Company's CFO. Thank you both for joining us today. Hopefully, everybody has caught up with the technology. There was a little bit of a lag but we are hopeful everyone is synced up.

Questions and Answers:

Steph Wissink - Jefferies - Analyst

So let us get started. I want to run through a number of topics, and we only have about 25 minutes, so we are going to do this pretty rapidly.

But the first question, Dan, is for you, is just to talk about the long-term growth targets of the business. What I love about it is it is symmetrical, 15% top-line growth, 15% operating margin. But give us some sense about how you think about kind of maintaining sustainability of demand and the demand strength you've been seeing with optimizing for that operating margin as well.

Dan
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot